Moomoo AI 已提取核心信息
Erqi Wang, a significant shareholder in Jin Medical International Ltd., has filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) on December 31, 2023, indicating a substantial ownership stake in the company. According to the filing, Wang holds a total of 107,126,140 ordinary shares, representing 68.43% of the company's class of securities after adjustments for a 20-for-1 forward stock split effective February 8, 2024. This ownership includes direct holdings through Jolly Harmony Enterprises Limited and Er Pu International Limited, both entities organized under the laws of the British Virgin Islands. Jolly Harmony Enterprises Limited, wholly owned by Wang, holds 95,381,140 shares, amounting to 60.93% of the class, while Er Pu International Limited, in which Wang has a 67% ownership, holds 11,745,000 shares, representing 7.50% of the class. The filing, completed on February 14, 2024, asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Jin Medical International Ltd.
Erqi Wang, a significant shareholder in Jin Medical International Ltd., has filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) on December 31, 2023, indicating a substantial ownership stake in the company. According to the filing, Wang holds a total of 107,126,140 ordinary shares, representing 68.43% of the company's class of securities after adjustments for a 20-for-1 forward stock split effective February 8, 2024. This ownership includes direct holdings through Jolly Harmony Enterprises Limited and Er Pu International Limited, both entities organized under the laws of the British Virgin Islands. Jolly Harmony Enterprises Limited, wholly owned by Wang, holds 95,381,140 shares, amounting to 60.93% of the class, while Er Pu International Limited, in which Wang has a 67% ownership, holds 11,745,000 shares, representing 7.50% of the class. The filing, completed on February 14, 2024, asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Jin Medical International Ltd.
金医疗国际有限公司的大股东王尔奇已于2023年12月31日向美国证券交易委员会（SEC）提交了附表13G，表明该公司拥有大量所有权。根据该文件，王共持有107,126,140股普通股，占公司证券类别的68.43％，此前调整了2024年2月8日生效的20比1远期股票拆分。这种所有权包括通过Jolly Harmony Enterprises Limited和Er Pu International Limited直接持有的股份，这两个实体均根据英属维尔京群岛法律组建由王全资拥有的Jolly Harmony Enterprises Limited持有95,381,140股股份，占该类别的60.93％；而王拥有67％所有权的二浦国际有限公司持有11,745,000股股份，占该类别的7.50％。该文件于2024年2月14日完成，声称这些股份是在正常业务过程中收购的，其目的不是为了改变或影响Jin Medical International Ltd的控制权。
金医疗国际有限公司的大股东王尔奇已于2023年12月31日向美国证券交易委员会（SEC）提交了附表13G，表明该公司拥有大量所有权。根据该文件，王共持有107,126,140股普通股，占公司证券类别的68.43％，此前调整了2024年2月8日生效的20比1远期股票拆分。这种所有权包括通过Jolly Harmony Enterprises Limited和Er Pu International Limited直接持有的股份，这两个实体均根据英属维尔京群岛法律组建由王全资拥有的Jolly Harmony Enterprises Limited持有95,381,140股股份，占该类别的60.93％；而王拥有67％所有权的二浦国际有限公司持有11,745,000股股份，占该类别的7.50％。该文件于2024年2月14日完成，声称这些股份是在正常业务过程中收购的，其目的不是为了改变或影响Jin Medical International Ltd的控制权。
有用
没用